BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Waters Corporation Acquires Light Scattering Leader Wyatt Technology

With more than 80% of its rapidly growing revenues tied to large molecule applications, Wyatt accelerates Waters' ability to build a high-growth business i...

May 17, 2023 | News

TVM Capital Healthcare opens office in Riyadh, Saudi Arabia

Establishing this local office comes after TVM Capital Healthcare successfully expanded its portfolio company Cambridge Medical and Rehabilitation Center f...

May 16, 2023 | News

Melanoma Research Alliance awards $6.3M in grants for prevention, detection, and treatment

MRA-funded research spans the entire spectrum of the disease including melanoma prevention, diagnosis, treatment, and metastatic disease. Melanoma is the d...

May 02, 2023 | News

Hasten Biopharma has secured a US$315 million fundraising round led jointly by CBC Group and Mubadala

CBC Group ("CBC"), Asia's largest healthcare-dedicated investment firm headquartered in Singapore, and Hasten Biopharmaceutic Company Limite...

April 20, 2023 | News

Roquette Cuts Ribbon on $25 Million Pharmaceutical Innovation Center in the United States

Staffed with a team of highly skilled research, application and formulation experts, the new $25 million center will be an advanced training and coll...

April 20, 2023 | News

Genscript Biotech Reports 2022 Annual Results

Revenue of the Group for the year ended December 31, 2022 was approximately US$625.7 million, representing an increase of 27.7% as compare...

March 31, 2023 | Company results

BIORCHESTRA Strikes $861M Deal for CNS-Targeted Nanoparticle Delivery of Nucleic Acid Therapies

BIORCHESTRA, a biotherapeutics company focused on the treatment of rare and degenerative diseases within the Central Nervous System (CNS) by leveragin...

March 28, 2023 | News

Everest Medicines receives full payment from Gilead for Trodelvy transaction, boosting cash reserves

"With the full upfront payment and other reimbursement from Gilead, we now have an even stronger balance sheet to advance development of products in our co...

March 28, 2023 | News

WuXi Biologics Reports Remarkable 2022 Annual Results

2022 Financial Highlights Revenue: The Group's revenue increased to RMB15,268.7 million with an increase of 48.4% y-o-y. The increase was...

March 23, 2023 | News

Etana has secured financing from Deg, East Ventures and other global investors

Etana is committed to build production capacity for mammalian cell for monoclonal antibodies drug substance to ensure high local content production a...

March 20, 2023 | News

Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results

Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics and precision oncology company, today announced financial r...

March 15, 2023 | News

Pfizer Invests $43 Billion to Battle Cancer

Pfizer to acquire Seagen for $229 per Seagen share in cash, for a total enterprise value of approximately $43 billion Proposed combination enhances Pfiz...

March 14, 2023 | News

Merck Achieves Profitable Growth in Challenging Fiscal 2022

Fiscal 2022 Group net sales rise 12.9% to € 22.2 billion EBITDA pre up 12.2% to € 6.8 billion EBITDA pre margin at 30.8% “Big 3&rdquo...

March 13, 2023 | News

Everest Medicines unaffected by Silicon Valley Bank developments.

The company's cash held at SVB is substantially less than 1% of its total cash balance, and amounts not covered by the Federal Deposit Insurance Corporatio...

March 13, 2023 | News

Stay Connected